A Minneapolis federal judge has overturned sanctions imposed last month on Boston Scientific in a whistleblower lawsuit lodged over two of its cardiac rhythm management devices. U.S. District Court Judge Joan Ericksen on Monday vacated the sanctions ordered Oct. 16 by the late Judge Steven Rau, according to a report by Law360. Rau had lambasted the […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
FDA approves Medtronic balloon to treat lesions hindering dialysis
Medtronic (NYSE:MDT) has secured FDA approval for its IN.PACT AV paclitaxel-coated balloon, meant to treat reoccurring blood vessel narrowing that delays people with end-stage renal disease from receiving needed dialysis. “In many cases, AV fistula are considered lifelines for patients with [end-stage renal disease] as they are the primary access point for life-saving dialysis treatment. When […]
LivaNova pulls the plug on transcatheter mitral valve repair device
LivaNova (NSDQ:LIVN) said today that it is ending its Caisson Interventional transcatheter mitral valve replacement (TMVR) program and plans to restructure its heart valve business to improve profitability. The company’s heart valve business represented nearly $130 million in revenue during fiscal 2018 and saw its revenue numbers decline over the last five years, both with biological […]
Stent makers point to quality-of-life findings by massive federal study
The giant federal study that found the use of stents in stable heart-disease patients is no better than drugs to treat clogged arteries reached another, less-hyped conclusion. Manufacturers of stents for percutaneous coronary intervention (PCI) note that the Ischemia study also concluded that patients who undergo a stenting procedure have a better quality of life. They suffer […]
Abiomed stock recovers some as company further questions critical Impella studies
Shares of heart pump company Abiomed (NSDQ:ABMD) recovered a bit today — a day after the company’s stock took a 20% dive after two critical studies came out of American Heart Association’s Scientific Sessions. The two separate studies — one led by researchers in St. Louis, the other out of San Francisco — suggested potentially serious complications […]
Getinge shares drop on news of more deaths, injuries linked to faulty IABPs
Shares of Getinge (STO:GETI-B) dropped 5% today on news that the FDA had received 60 more reports of adverse events — including two deaths and one serious injury — related to the company’s Maquet/Datascope intraortic balloon pumps (IABP). The FDA said the new reports have come in since it issued a letter in November 2018 […]
BioVentrix wins breakthrough nod for transcatheter-based structural heart device
BioVentrix announced today that it won FDA breakthrough device designation for its Revivent TC transcatheter ventricular enhancement system for heart failure. The Revivent TC system is used in less invasive ventricular enhancement (LIVE) procedures intended to exclude scar tissue on the left ventricle that resulted from a heart attack so that the healthy portion of […]
BREAKING: Abiomed stock down 20% after new research raises questions about Impella
Shares of heart pump company Abiomed (NSDQ:ABMD) fell today after research released over the weekend suggested potentially serious complications involving the company’s Impella heart pumps. Abiomed stock was down more than 20%, to $178.09 per share, by the close of trading after news of the two studies came out of the American Heart Association’s Scientific Sessions […]
Boston Scientific issues safety notice for AngioJet Ultra consoles
Boston Scientific (NYSE:BSX) issued an urgent field safety notice to inform users of a correction to its AngioJet Ultra consoles that were shipped to customers without the required operator’s manual. The company said the consoles meet design specifications and are expected to perform as intended, as Boston Scientific determined that the correct use of the […]
Study: Stents no better than drugs for stable heart disease
This article has been updated with stock market results and comments from Medtronic. A major new study has concluded that the use of stents in stable heart disease patients is no better than drugs to treat clogged arteries. Results of the Ischemia study were released at the American Heart Association annual meeting in Philadelphia on Saturday. The […]
Edwards issues recall for Pascal guide sheaths
Edwards Lifesciences (NYSE:EW) issued a product recall for its guide sheath used with the Edwards Pascal transcatheter valve repair system. The company is recalling all lots of the product after it identified potential for damage to the Pascal guide sheath’s inner line due to a manufacturing issue. Edwards found that the issue has occurred in 0.5% […]